Microplastics and Human Health: What Medicine Is Beginning to Understand.

David S. Klein, MD FACA FACPM
3 days ago
5 min read

Simple diagram showing how microplastics enter the body through food, water, and air, leading to systemic exposure over time. — Microplastics Exposure Pathways in Humans

For decades, plastic was regarded as biologically inert—an engineering success with little relevance to human physiology. That assumption is now being actively challenged.

Microplastics and nanoplastics, defined as plastic fragments smaller than 5 mm and often far smaller than a human cell, have now been identified in human blood, lung tissue, stool, placenta, breast milk, and atherosclerotic plaques¹⁻⁴.

Microplastics and human health: The medical implications are no longer speculative. They are measurable, reproducible, and increasingly relevant to everyday clinical practice.

What Are Microplastics—and Why Size Matters

Microplastics originate from the degradation of larger plastic products (bottles, packaging, synthetic clothing, tire wear) as well as from intentionally manufactured particles used in industry and consumer goods.

As particle size decreases, biological relevance increases:

>150 µm: typically excreted
10–150 µm: may cross intestinal or pulmonary epithelium
<1 µm (nanoplastics): capable of cellular uptake and systemic distribution⁵

At this scale, plastics cease to behave as inert debris and begin functioning as biologically active particulates.

Routes of Human Exposure

Human exposure is now continuous and unavoidable:

Ingestion: bottled water, seafood, salt, packaged foods⁶⁻⁸
Inhalation: indoor dust, synthetic fibers, urban air pollution⁹
Dermal contact: limited absorption, but relevant for chemical additives

Once internalized, microplastics may persist in tissues for prolonged periods, particularly when embedded in inflammatory or lipid-rich environments.

Visual overview of how microplastics may contribute to inflammation, hormonal disruption, gut barrier dysfunction, and cardiovascular risk. — Potential Health Effects of Microplastics

Gastrointestinal and Metabolic Effects

The gastrointestinal tract represents the primary interface between microplastics and human physiology. Experimental and observational studies demonstrate:

Disruption of intestinal epithelial tight junctions
Increased intestinal permeability
Alteration of gut microbiota composition
Local immune activation and oxidative stress¹⁰⁻¹²

These mechanisms intersect directly with conditions routinely managed in clinical practice, including insulin resistance, metabolic syndrome, inflammatory bowel disease, and MASLD.

Endocrine and Hormonal Disruption

Microplastics act not only as particles but as chemical vectors. Many carry or adsorb endocrine-active compounds such as bisphenols, phthalates, and persistent organic pollutants¹³.

Documented and proposed effects include:

Interference with estrogen, androgen, and thyroid hormone signaling
Disruption of nuclear receptor activity
Epigenetic modification of gene expression¹⁴⁻¹⁶

From a clinical perspective, these findings raise concerns regarding fertility, pubertal development, thyroid disease, and hormonally mediated cancers.

Cardiovascular and Inflammatory Risk

Recent human data have identified microplastics within atherosclerotic plaques, a finding associated with increased local inflammation and adverse cardiovascular outcomes¹⁷.

While causality has not yet been established, the pattern mirrors prior environmental exposures now recognized as cardiovascular risk modifiers: chronic inflammation, oxidative stress, and endothelial dysfunction.

Neuroimmune and Developmental Considerations

Animal models and early human evidence suggest that nanoplastics may cross both the blood–brain barrier and the placental barrier¹⁸⁻²⁰.

This raises clinically relevant—but as yet unanswered—questions regarding:

Neuroinflammation and microglial activation
Prenatal immune programming
Long-term neurodevelopmental effects

Medicine has encountered this trajectory before. Lead, asbestos, and tobacco followed a similar arc: widespread exposure preceded mechanistic clarity.

Microplastics and human health. Practical Risk Reduction: What Patients Can Do Now

Patient-friendly infographic outlining simple lifestyle steps that may reduce microplastic exposure and support long-term health. — Ways to Reduce Microplastic Exposure

While definitive clinical guidelines are still evolving, several low-risk, evidence-aligned strategies are reasonable:

Prefer glass or stainless steel for food and beverages
Avoid heating food in plastic containers
Use filtered drinking water when feasible
Reduce consumption of ultra-processed and heavily packaged foods
Support metabolic and inflammatory resilience through nutrition, exercise, sleep, and stress management

The goal is risk reduction, not elimination—an unrealistic expectation in modern environments.

A Measured Medical Perspective

Microplastics should not be framed as a source of alarm, nor dismissed as irrelevant. They represent a novel, cumulative exposure interacting with inflammation, metabolism, endocrine signaling, and immune regulation.

Medicine is still defining the contours of this risk. However, history suggests that early biological signals deserve attention, particularly when exposure is lifelong and ubiquitous.

Environmental exposures intersect with inflammation, metabolism, and hormonal balance. If you are concerned about long-term health resilience, a personalized medical evaluation can help identify modifiable risk factors.

👉 Schedule a consultation with Stages of Life Medical Institute.

REFERENCES

Leslie HA, van Velzen MJM, Brandsma SH, Vethaak AD, Garcia-Vallejo JJ, Lamoree MH. Discovery and quantification of plastic particle pollution in human blood. Environ Int. 2022;163:107199.https://pubmed.ncbi.nlm.nih.gov/35056410/
Ragusa A, Svelato A, Santacroce C, et al. Plasticenta: First evidence of microplastics in human placenta. Environ Int. 2021;146:106274.https://pubmed.ncbi.nlm.nih.gov/33395930/
Schwabl P, Köppel S, Königshofer P, et al. Detection of various microplastics in human stool: A prospective case series. Ann Intern Med. 2019;171(7):453-457.https://pubmed.ncbi.nlm.nih.gov/31476765/
Marfella R, Prattichizzo F, Sardu C, et al. Microplastics and nanoplastics in atherosclerotic plaques and cardiovascular events. N Engl J Med. 2024;390(10):900-910.https://pubmed.ncbi.nlm.nih.gov/38388430/
Wright SL, Kelly FJ. Plastic and human health: A micro issue? Environ Sci Technol. 2017;51(12):6634-6647.https://pubmed.ncbi.nlm.nih.gov/29161219/
Cox KD, Covernton GA, Davies HL, Dower JF, Juanes F, Dudas SE. Human consumption of microplastics. Environ Sci Technol. 2019;53(12):7068-7074.https://pubmed.ncbi.nlm.nih.gov/31151256/
Kosuth M, Mason SA, Wattenberg EV. Anthropogenic contamination of tap water, beer, and sea salt. Front Chem. 2018;6:407.https://pubmed.ncbi.nlm.nih.gov/30062106/
Karami A, Golieskardi A, Choo CK, Larat V, Galloway TS, Salamatinia B. The presence of microplastics in commercial salts from different countries. Sci Rep. 2017;7:46173.https://pubmed.ncbi.nlm.nih.gov/28724929/
Vianello A, Jensen RL, Liu L, Vollertsen J. Simulating human exposure to indoor airborne microplastics using a breathing thermal manikin. PLoS One. 2019;14(1):e0211020.https://pubmed.ncbi.nlm.nih.gov/30668565/
Jin Y, Lu L, Tu W, Luo T, Fu Z. Impacts of polystyrene microplastic on the gut barrier, microbiota, and metabolism of mice. Chemosphere. 2019;237:124433.https://pubmed.ncbi.nlm.nih.gov/30844682/
Lu L, Wan Z, Luo T, Fu Z, Jin Y. Polystyrene microplastics induce gut microbiota dysbiosis and hepatic lipid metabolism disorder in mice. Sci Total Environ. 2018;631-632:449-458.https://pubmed.ncbi.nlm.nih.gov/29609994/
Hirt N, Body-Malapel M. Immunotoxicity and intestinal effects of nano- and microplastics. Part Fibre Toxicol. 2020;17(1):57.https://pubmed.ncbi.nlm.nih.gov/34391635/
Rochman CM, Hentschel BT, Teh SJ. Long-term sorption of metals is similar among plastic types: Implications for plastic debris in aquatic environments. Sci Rep. 2013;3:3263.https://pubmed.ncbi.nlm.nih.gov/23862916/
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293-342.https://pubmed.ncbi.nlm.nih.gov/19416694/
Trasande L, Zoeller RT, Hass U, et al. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union. Lancet Diabetes Endocrinol. 2015;3(12):996-1002.https://pubmed.ncbi.nlm.nih.gov/32085892/
Li J, Yang D, Li L, Jabeen K, Shi H. Microplastics in commercial bivalves from China. J Hazard Mater. 2020;399:123999.https://pubmed.ncbi.nlm.nih.gov/32086005/
Marfella R, Sardu C, Prattichizzo F, et al. Microplastic accumulation and cardiovascular outcomes. N Engl J Med. 2024;390(10):900-910.https://pubmed.ncbi.nlm.nih.gov/38388430/
Prüst M, Meijer J, Westerink RHS. The plastic brain: Neurotoxicity of micro- and nanoplastics. Environ Health Perspect. 2020;128(12):123001.https://pubmed.ncbi.nlm.nih.gov/32167873/
Fournier SB, D’Errico JN, Adler DS, et al. Nanopolystyrene translocation and fetal deposition after acute lung exposure during pregnancy. Toxicol Sci. 2020;175(1):56-69.https://pubmed.ncbi.nlm.nih.gov/31912157/
Wick P, Malek A, Manser P, et al. Barrier capacity of human placenta for nanosized materials. Environ Health Perspect. 2010;118(3):432-436.https://pubmed.ncbi.nlm.nih.gov/20826301/

The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances.

Subscribe to our Blog